Insider Transactions in Q3 2021 at Outset Medical, Inc. (OM)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
5,184
-28.27%
|
$285,120
$55.0 P/Share
|
|
Sep 17
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,184
+22.04%
|
$5,184
$1.11 P/Share
|
|
Sep 17
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
15,000
-5.65%
|
$825,000
$55.0 P/Share
|
|
Sep 17
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+5.35%
|
$30,000
$2.93 P/Share
|
|
Sep 17
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,000
-41.26%
|
$715,000
$55.0 P/Share
|
|
Sep 17
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+29.21%
|
$39,000
$3.88 P/Share
|
|
Sep 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
4,945
-13.82%
|
$247,250
$50.38 P/Share
|
|
Sep 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,945
+11.97%
|
$44,505
$9.48 P/Share
|
|
Sep 07
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
2,890
-8.76%
|
$144,500
$50.0 P/Share
|
|
Sep 07
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,890
+8.06%
|
$26,010
$9.48 P/Share
|
|
Sep 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-35.08%
|
$490,000
$49.17 P/Share
|
|
Sep 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.97%
|
$30,000
$3.88 P/Share
|
|
Sep 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-3.81%
|
$980,000
$49.16 P/Share
|
|
Sep 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.64%
|
$40,000
$2.93 P/Share
|
|
Sep 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
1,296
-28.27%
|
$63,504
$49.17 P/Share
|
|
Sep 01
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,296
+22.04%
|
$1,296
$1.11 P/Share
|
|
Aug 26
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
1,296
-28.27%
|
$58,320
$45.0 P/Share
|
|
Aug 26
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,296
+22.04%
|
$1,296
$1.11 P/Share
|
|
Aug 16
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-19.26%
|
$133,000
$38.68 P/Share
|
|
Aug 16
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
|
Aug 11
2021
|
James F. Hinrichs Director |
BUY
Open market or private purchase
|
Direct |
10,000
+23.1%
|
$360,000
$36.66 P/Share
|
|
Aug 10
2021
|
Nabeel Ahmed Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+3.15%
|
$37,000
$37.13 P/Share
|
|
Aug 05
2021
|
Nabeel Ahmed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,398
+36.53%
|
-
|
|
Aug 02
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-7.4%
|
$800,000
$40.62 P/Share
|
|
Aug 02
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.89%
|
$40,000
$2.93 P/Share
|
|
Aug 02
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-35.08%
|
$200,000
$40.71 P/Share
|
|
Aug 02
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+25.97%
|
$15,000
$3.88 P/Share
|
|
Jul 16
2021
|
Nabeel Ahmed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,575
+50.0%
|
-
|
|
Jul 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-19.26%
|
$150,500
$43.83 P/Share
|
|
Jul 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
|
Jul 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
42,500
-4.06%
|
$2,082,500
$49.25 P/Share
|
|
Jul 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,500
+3.89%
|
$85,000
$2.48 P/Share
|
|
Jul 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
1,296
-28.27%
|
$63,504
$49.23 P/Share
|
|
Jul 01
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,296
+22.04%
|
$1,296
$1.11 P/Share
|
|
Jul 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,000
-36.49%
|
$784,000
$49.25 P/Share
|
|
Jul 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+26.72%
|
$48,000
$3.88 P/Share
|